Seeing into the Future: HeartMate 3 to the Systemic Right Ventricle in a Completely Blind Patient with Congenitally-corrected Transposition of the Great Arteries

A 24-year-old, blind male with congenitally-corrected transposition of the great arteries and systemic right ventricular failure presented with New York Heart Association class IV heart failure despite home inotropic therapy. He was not a transplant candidate due to psychosocial issues. He underwent a successful HeartMate 3 (Abbott Laboratories) placement with the implementation of techniques to guide home ventricular assist device care despite blindness.